Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze

Stock is trading at $28 compared with Eli Lilly’s $739 price tag. That could change if a trial of a pill version of its GLP-1 drug proves effective.

Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
Stock is trading at $28 compared with Eli Lilly’s $739 price tag. That could change if a trial of a pill version of its GLP-1 drug proves effective.